05/26/2026
Ohio State is now ranked #28 among all U.S. institutions in the
Cure Innovation Index, a national benchmark measuring strength in translating biomedical research into real-world impact. The new ranking reflects Ohio State’s increasing momentum in innovation, commercialization and clinical translation.
https://news.osu.edu/ohio-state-earns-top-30-national-ranking-in-innovation-index/
“This recognition affirms the intentional work we have done to move discovery out of the lab and into the world where it can improve lives,” said John Horack, vice president for research. “Our research community is focused not only on breakthrough science, but on ensuring those discoveries translate into therapies, diagnostics, and technologies that make a meaningful difference.”
The Cure Innovation Index evaluates universities on a range of indicators tied to biomedical innovation, including startup creation, industry partnerships, licensing activity, and the development of treatments that reach patients. Ohio State’s performance highlights its strength in connecting fundamental research with commercialization pathways.
A key driver of this success has been the university’s growing patent portfolio. The increase in patents reflects an expanding culture of innovation among faculty, researchers, and students, as well as strategic investments in infrastructure that supports invention disclosure, protection, and market translation.
According to recent national patent rankings by the National Academy of Inventors, Ohio State has climbed to No. 21 among U.S. universities and No. 30 globally, underscoring a sustained commitment to research that leads to tangible solutions in health care, technology, and beyond.
The Ohio State University was ranked 28th among all U.S. institutions in the Cure Innovation Index, a national benchmark measuring strength in translating biomedical research into real-world impact.The new ranking reflects Ohio State’s increasing momentum in innovation, commercialization, and clin...